Uncategorized

 Amgen will gain access to Tavneos, Chemocentryx’s oral small molecule drug, designed to selectively inhibit the complement component 5a receptor (C5aR), to treat autoimmune and inflammatory diseases Amgen has signed a definitive agreement to acquire ChemoCentryx, a biopharmaceutical company focused…

  Through the acquisition, Gilead will obtain MiroBio’s unique I-ReSToRE drug discovery platform, along with its complete range of investigational immune inhibitory receptor agonist therapies US-based biopharmaceutical firm Gilead Sciences has signed a definitive agreement to acquire all of the…

Juvéderm Volux XC is said to be the first and only hyaluronic acid (HA) filler to receive US FDA approval for improving jawline definition, and sixth product in the company’s Juvéderm family of fillers Allergan Aesthetics, a subsidiary of AbbVie,…

    The EMA has extended the approved indications of Bavarian Nordic’s smallpox vaccine Imvanex for monkeypox, which has now infected tens of thousands of people across dozens of countries worldwide. Imvanex has been approved in the EU since 2013…

British multinational GlaxoSmithKline announced Wednesday that the U.S. Food and Drug Administration gave its Benlysta (belimumab) the greenlight for use against active lupus nephritis in children aged 5 to 17 on standard therapy. The FDA’s nod extends Benlysta’s indication in the US, making it the…

For individuals with weak eyes, spectacles and eyeglasses are unquestionably a blessing. They allow you to walk without tripping over objects, read, and essentially just see what’s in front of you. But they can also be a curse. It is…

AstraZeneca has signed a deal to buy US biotech TeneoTwo in a deal worth up to $1.27 billion that will boost its position therapies for haematological cancers. The big pharma is paying $100 million upfront for the company, and offering…

Cancer drugs will be flown from a facility in Portsmouth to a hospital on the Isle of Wight by drone, in the first pilot study of the technology by NHS England. The trial – announced this morning and said to…

Bayer has stepped up the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI and CT imaging. The cloud-hosted platform – called Calantic Digital Solutions – has tools to help radiologists detect and…

According to the draft document prepared by the department of pharmaceuticals, the sector spends an average of 5-6% of its revenues on R&D, which should increase to at least 15% With an aim of improving India’s position in the global…